Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Effect of the Length of Second Stage of Labor in Primigravidae on Maternal & Neonatal Outcomes (RCT)

torstai 4. helmikuuta 2016 päivittänyt: Mohamed El-Sharkawy, Kasr El Aini Hospital
The primary purpose of this study is to compare the effects of two different methods of care during the second stage of labor for nulliparous women (coached versus uncoached pushing) on the length of the second stage and how this may affect maternal and neonatal outcome.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

The study was conducted on 434 primigravidae women admitted to Kasr El Ainy teaching Maternity Hospital for labor. The study will be done in the period between October 2015 and April 2016. The study will include 434 women with the diagnosis of the first stage of labor with at least cervical dilatation 4cm.

Ethical approval obtained and an informed consent will be taken from each patient after explaining the nature and scope of the study.

Methodology in details:

  1. Careful and detailed history taking regarding:

    • Personal history
    • Complaint.
    • History of present pregnancy.
    • Menstrual History.
    • Past history.
  2. Careful general examination.
  3. Abdominal examination.
  4. Local vaginal examination.
  5. Ultrasound examination.

Management of Cases:

Group (I)(Coached group):

It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward. They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth. The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds.

Group (II)(Uncoached group):

It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth. .

Patients admitted early in labor are subjected to active management of labor as follows:

Pelvic examination performed. Routine amniotomy performed and progress assessed. When dilatation is not increasing, a low dose protocol of oxytocin infusion will be started. Oxytocin diluted in the form of 5IU in 500 ml Ringer lactate making a concentration of nearly 1mu oxytocin/1ml Ringer solution. Infusion instituted at a rate of 1 -2 milliunit (15-30 drops) per minute and increased gradually in increments of 1 -2 milliunit per minute at 30 minutes interval, until at least three uterine contractions noted in a 10 minute period using cardio tocograph.

Assessment of each stage of labor was performed as follow:

  1. First stage of labor:

    It includes:

    • Duration of the first stage of labor.
    • Rate of cervical dilatation and foetal descent.
    • Adequacy of uterine contractions and documentation of labor dystocia.
    • Excess uterine activity consisted of uterine tachysystole, hypertonus or uterine hyperstimulation
  2. Second stage of labor:

    It includes:

    • Duration of the second stage.
    • Rate of the descent of foetus.
    • Monitoring of foetal heart rate every 5 minutes by sonicaid or continuous by CTG.
    • Use of mediolateral episiotomy.
    • Intervention will be considered either by instrumental delivery,fundal pressure or by CS If the second stage is prolonged more than 2 hours.
    • Monitoring of maternal oxygen saturation by pulse oximeter.
  3. Third stage of labor:

    - Duration of the third stage.

  4. Assessment of any vaginal laceration or perineal tears with their repair as well as repair of episiotomy.
  5. Assessment of quantity of blood loss and assessment of uterine atony(vital instability,number of soaked pads and hemoglobin drop) .
  6. Rate of caesarean section during varying stages of labor.
  7. Neonatal assessment:

It includes:

  • Foetal sex and body weight.
  • APGAR score at 1 and 5 minutes..

Opintotyyppi

Havainnollistava

Ilmoittautuminen (Odotettu)

434

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta - 35 vuotta (Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Nainen

Näytteenottomenetelmä

Todennäköisyysnäyte

Tutkimusväestö

The study was conducted on 434 primigravidae women admitted to Kasr El Ainy teaching Maternity Hospital for labor. The study will be done in the period between October 2015 and April 2016. The study will include 434 women with the diagnosis of the first stage of labor with at least cervical dilatation 4cm.

Kuvaus

Inclusion Criteria:

All patients admitted in the first stage of labor with cervical dilatation of 4 cm at least:

  1. Women age 18-35 years.
  2. 37-41 weeks gestation pregnancy.
  3. Singleton pregnancy and vertex presentation.
  4. Women have no chronic or pregnancy-induced illnesses.
  5. Women are in established, spontaneous labor.

Exclusion Criteria:

  1. Malpresentation.
  2. Women with previous uterine scar.
  3. Multiple pregnancy
  4. Ante partum hemorrhage.
  5. Cephalopelvic disproportion.
  6. Women have chronic illnesses.
  7. Women with abnormal antenatal period.
  8. Patients with foetal distress
  9. Premature rupture of membrane
  10. Woman having any contraindication to vaginal delivery.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Havaintomallit: Case-Control
  • Aikanäkymät: Tulevaisuuden

Kohortit ja interventiot

Ryhmä/Kohortti
Interventio / Hoito
1

Group (I)(Coached group):

It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward. They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth. The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds.

It includes 217 patients who are admitted in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward. They are coached by the nurse to use closed-glottis and pushing three to four times during each contraction immediately when cervical dilation reached 10 cm and to continue pushing using this method with each contraction until birth. The nurse counts to 10 during each pushing effort to assist the woman in holding her breath for at least 10 seconds.
2
It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth.
It includes 217 patients who are admitted early in active stage of labor (cervical dilatation 4cm at least) to labor delivery ward at 10-cm cervical dilation where they remain until they feel the urge to push or the second stage had lasted 2 hours (whichever came first)., they are encouraged to bear down with contractions without holding their breath (open-glottis) for no more than 6-8 seconds and continue bearing down no more than three times with each contraction until birth. .

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Aikaikkuna
Duration of the second stage
Aikaikkuna: 0-3 hours
0-3 hours

Toissijaiset tulostoimenpiteet

Tulosmittaus
Aikaikkuna
Severe maternal morbidity e.g post partum hemorrhage
Aikaikkuna: intrapartum and 2 hours postpartum.
intrapartum and 2 hours postpartum.
APGAR score after one and five minutes.
Aikaikkuna: 1-5 minutes
1-5 minutes

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Opintojohtaja: Kasr El Ainy, hospital, kasr el ainy street,cairo,egypt

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus

Sunnuntai 1. marraskuuta 2015

Ensisijainen valmistuminen (Odotettu)

Sunnuntai 1. toukokuuta 2016

Opintojen valmistuminen (Odotettu)

Sunnuntai 1. toukokuuta 2016

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Perjantai 20. marraskuuta 2015

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Torstai 4. helmikuuta 2016

Ensimmäinen Lähetetty (Arvio)

Maanantai 8. helmikuuta 2016

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Arvio)

Maanantai 8. helmikuuta 2016

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Torstai 4. helmikuuta 2016

Viimeksi vahvistettu

Maanantai 1. helmikuuta 2016

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muut tutkimustunnusnumerot

  • KasrELAini maternity hospital

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa